Non-small cell lung cancer cell survival crucially depends on functional insulin receptors.

作者: Carolin Maria Frisch , Katrin Zimmermann , Pia Zilleßen , Alexander Pfeifer , Kurt Racké

DOI: 10.1530/ERC-14-0581

关键词:

摘要: Insulin plays an important role as a growth factor and its contribution to tumor proliferation is intensely discussed. It acts via the cognate insulin receptor (IR) but can also activate IGF1 (IGF1R). Apart from increasing proliferation, might have additional effects in lung cancer. Therefore, we investigated action of IR knockdown (KD) three (NCI-H292, NCI-H226 NCI-H460) independent non-small cell cancer (NSCLC) lines. All lines studied were found express IR, albeit with marked differences ratio two variants IR-A IR-B. activated classical signaling pathway autophosphorylation Akt phosphorylation. Moreover, activation MAPK was observed H292 cells, accompanied by enhanced proliferation. Lentiviral shRNA KD caused strong decrease survival all lines, indicating that go beyond enhancing Unspecific ruled out employing further shRNAs different insulin-responsive cells (human pre-adipocytes) for comparison. Caspase assays demonstrated strongly induced apoptosis these providing physiological basis rapid loss. In search underlying mechanism, analyzed alterations gene expression profile response KD. A induction certain cytokines (e.g. IL20 tumour necrosis factor) became obvious it turned trigger NSCLC tested. This indicates novel suppression pro-apoptotic cytokines.

参考文章(42)
Tricia Santos Cavaiola, Steven Edelman, Inhaled insulin: a breath of fresh air? A review of inhaled insulin. Clinical Therapeutics. ,vol. 36, pp. 1275- 1289 ,(2014) , 10.1016/J.CLINTHERA.2014.06.025
Peter Mayer, Ulrich Reitzenstein, Mareille Warnken, Harald Enzmann, Kurt Racké, Insulin action on H292 bronchial carcinoma cells as compared to normal bronchial epithelial cells. Pulmonary Pharmacology & Therapeutics. ,vol. 25, pp. 104- 114 ,(2012) , 10.1016/J.PUPT.2011.12.005
R. Vigneri, S. Squatrito, L. Sciacca, Insulin and its analogs: actions via insulin and IGF receptors Acta Diabetologica. ,vol. 47, pp. 271- 278 ,(2010) , 10.1007/S00592-010-0215-3
Cullen M. Taniguchi, Brice Emanuelli, C. Ronald Kahn, Critical nodes in signalling pathways: Insights into insulin action Nature Reviews Molecular Cell Biology. ,vol. 7, pp. 85- 96 ,(2006) , 10.1038/NRM1837
Sonja Matthiesen, Amit Bahulayan, Susanne Kempkens, Susanne Haag, Margarita Fuhrmann, Christine Stichnote, Uwe R. Juergens, Kurt Racké, Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. American Journal of Respiratory Cell and Molecular Biology. ,vol. 35, pp. 621- 627 ,(2006) , 10.1165/RCMB.2005-0343RC
S. C. Larsson, N. Orsini, K. Brismar, A. Wolk, Diabetes mellitus and risk of bladder cancer : a meta-analysis Diabetologia. ,vol. 49, pp. 2819- 2823 ,(2006) , 10.1007/S00125-006-0468-0
Robert C. Baxter, IGF binding proteins in cancer: mechanistic and clinical insights Nature Reviews Cancer. ,vol. 14, pp. 329- 341 ,(2014) , 10.1038/NRC3720
Raymond P. Donnelly, Faruk Sheikh, Sergei V. Kotenko, Harold Dickensheets, The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain Journal of Leukocyte Biology. ,vol. 76, pp. 314- 321 ,(2004) , 10.1189/JLB.0204117
Hashem B. El–Serag, Howard Hampel, Fariba Javadi, The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic Evidence Clinical Gastroenterology and Hepatology. ,vol. 4, pp. 369- 380 ,(2006) , 10.1016/J.CGH.2005.12.007